Pediatrics
News
EC approves new use, formulation of dasatinib
The European Commission (EC) has expanded the marketing authorization for dasatinib (Sprycel). The drug is now approved to treat patients ages 1...
News
Many CCSs not concerned about future health
A survey of more than 15,000 childhood cancer survivors (CCSs) revealed that many were unconcerned about their risk of health problems. Thirty-...
Latest News
New NIH consortium aims to coordinate pediatric research programs
The organization will harmonize activities, set priorities, explore gaps, and find opportunities in NIH’s pediatric research.
News
Mircera approved for anemia in pediatric patients with CKD
Mircera®, methoxy polyethylene glycol-epoetin beta, was approved by the US Food and Drug Administration (FDA) to treat anemia in pediatric...
Conference Coverage
Youth with rhabdomyosarcoma see better survival with maintenance chemo
CHICAGO – These findings mark the first major advance for this rare cancer in 30 years and have led to a new standard of care in Europe.
News
Dasatinib outcomes similar to imatinib in pediatric Ph+ ALL
Dasatinib used during induction and consolidation in the Children’s Oncology Group (COG) AALL0622 trial provided early response rates for children...
Video
Maintenance chemo boosts survival for youth with high-risk rhabdomyosarcoma
CHICAGO - Lead study author Dr. Gianni Bisogno discusses the practice changing results and describes plans for a new trial to explore alternate...
News
VF incidence increases significantly in kids after ALL treatment
A 6-year prospective study from the Canadian STOPP investigators revealed that following treatment for acute lymphoblastic leukemia (ALL),...
News
Early infection could prevent ALL, doc says
Childhood acute lymphoblastic leukemia (ALL) may be preventable, according to a researcher. Mel Greaves, PhD, of The Institute of Cancer Research...
Conference Coverage
New regimens for youth with T-cell malignancies yield best outcomes yet
More than 8 in 10 youth were still alive and free of disease 4 years after starting combinations of methotrexate and/or nelarabine with chemo.
Conference Coverage
Pediatric cancers are on the rise
PITTSBURGH – CDC investigators detected a significant increase in pediatric cancers from 2001 through 2014, although the reasons for the rise are...